Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Cell-based Biological Reagents Market Revenue Growth On Track For A 8.6% CAGR Through 2030
The cell-based biological reagents market size has experienced robust growth recently. This market is projected to expand, reaching $14.93 billion in 2026 from $13.78 billion in 2025, driven by an 8.3% compound annual growth rate (CAGR). Historically, this growth can be attributed to the expansion of drug discovery research activities, increased pharmaceutical R&D spending, the growing use of cell-based assays in toxicity testing, advancements in cell culture technologies, and the rising adoption of standardized biological reagents.
The market for cell-based biological reagents is projected to experience substantial growth over the coming years. Its valuation is anticipated to reach $20.74 billion by 2030, demonstrating an 8.6% compound annual growth rate (CAGR). This expansion during the forecast timeframe is attributable to several factors, including the rising need for predictive in vitro models, the expansion of personalized medicine research, the increasing application of AI-driven drug screening, growing investments in regenerative medicine studies, and an enhanced focus on complex disease modeling. Key trends expected during this period involve the increasing adoption of 3D cell culture and assay platforms, the growing utilization of gene-edited and reporter cell lines, an escalating demand for high-throughput cell-based screening, the broadening of stem cell and primary cell applications, and a heightened emphasis on physiologically relevant models.
Get A Free Sample Report With In-Depth Market Insights:
Cell-based Biological Reagents Market Growth Factors: What’s Supporting Expansion?
The growing emphasis on cell and gene therapies is anticipated to drive the expansion of the cell-based biological reagents market in the future. These therapies involve interventions that utilize live cells or genetic elements to mend, substitute, or alter compromised cells or genes, aiming to treat or resolve illnesses. The application of cell and gene therapies is expanding because of the increasing occurrence of rare and genetic conditions, as these treatments provide potential cures by addressing the root causes at a cellular or genetic level, in contrast to traditional methods that typically only manage symptoms. Cell-based biological reagents facilitate cell and gene therapies by furnishing the necessary instruments and substances for the efficient cultivation, modification, and administration of therapeutic cells or genetic components. A notable instance is the global expenditure on cell and gene therapies, which, as reported in March 2024 by IQVIA Holdings Inc., a US-based healthcare company focused on clinical research services and analytics, escalated to $5.9 billion in 2023, representing a 38% increase from 2022. Consequently, the increased attention on cell and gene therapies is fueling the expansion of the cell-based biological reagents market.
Cell-based Biological Reagents Market Segment Breakdown: Which Categories Lead On Revenue?
The cell-based biological reagents market covered in this report is segmented –
1) By Product Type: Assay Kits; Cell Lines; Reagents; Other Product Types
2) By Technology: Two Dimensional Cell Culture; Three Dimensional Cell Culture; High Throughput Screening Platforms; Stem Cell Technologies; Gene Edited Cell Platforms
3) By Application: Drug Discovery And Development; Toxicology And Safety Assessment; Disease Modeling; Regenerative Medicine; Basic Research
4) By End User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations; Clinical And Diagnostic Laboratories; Government And Public Health Agencies
Subsegments:
1) By Assay Kits: Cell Viability Assay Kits; Cytotoxicity Assay Kits; Proliferation Assay Kits; Apoptosis Assay Kits; Signal Transduction Assay Kits
2) By Cell Lines: Primary Cell Lines; Immortalized Cell Lines; Stem Cell Lines; Cancer Cell Lines; Transfected Cell Lines
3) By Reagents: Culture Media Reagents; Growth Factor Reagents; Enzyme Reagents; Supplement Reagents; Antibody Reagents
4) By Other Product Types: Cryopreservation Reagents; Labware Consumables; Transfection Reagents; Cell Sorting Reagents; Custom Reagents
Cell-based Biological Reagents Market Industry Trends: What’s Reshaping Demand?
Major companies operating in the cell-based biological reagents market are concentrating on developing human-induced pluripotent stem cell (iPSC) research offerings to advance drug discovery, disease modeling, and regenerative medicine applications. Human-induced pluripotent stem cell (iPSC) research products are integrated tools and workflows designed to enable the generation, maintenance, differentiation, and analysis of iPSCs for various biomedical research applications, including drug screening, disease understanding, and cell therapy innovation. For example, in July 2024, BioServe Biotechnologies (India) Private Limited, an India-based biotechnology company, unveiled an advanced stem cell product range to accelerate regenerative medicine and drug development research. This line enhances biotech research via reliable iPSC generation, 3D organoid cultures, and targeted differentiation tools, thereby minimizing experimental variability. These offerings streamline drug discovery by providing human-specific models that reduce animal testing and speed up toxicity assessments, leading to faster therapy development. Ultimately, they empower personalized medicine, facilitating tissue regeneration for conditions like diabetes or heart failure while simultaneously cutting costs and reducing rejection risks.
Cell-based Biological Reagents Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the cell-based biological reagents market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Corp., Danaher Corporation, GE Healthcare, Becton, Dickinson And Company, Corning Incorporated, Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., STEMCELL Technologies Inc., Miltenyi Biotec, Abcam plc, Promega Corporation, Takara Bio Inc., R&D Systems Inc., MP Biomedicals, Sino Biological, Cell Signaling Technology Inc., InvivoGen, Tocris Bioscience, and OPM Biosciences.
View The Full Cell-based Biological Reagents Market Report:
Cell-based Biological Reagents Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the cell-based biological reagents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell-based biological reagents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
